Tharimmune, Inc.
THAR
$1.21
-$0.0002-0.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.48% | 6.94% | 3.94% | 6.20% | 28.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.50% | 27.93% | 1.38% | 10.22% | 37.39% |
| Operating Income | -31.50% | -27.93% | -1.38% | -10.22% | -37.39% |
| Income Before Tax | -30.89% | -26.00% | 0.49% | -8.12% | -9.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.89% | -26.00% | 0.49% | -8.12% | -9.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.89% | -26.00% | 0.49% | -8.12% | -9.98% |
| EBIT | -31.50% | -27.93% | -1.38% | -10.22% | -37.39% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 94.79% | 92.20% | 79.19% | 60.69% | 33.21% |
| Normalized Basic EPS | 94.79% | 92.20% | 79.19% | 60.69% | 33.21% |
| EPS Diluted | 94.79% | 92.20% | 79.19% | 60.69% | 33.21% |
| Normalized Diluted EPS | 94.79% | 92.20% | 79.19% | 60.69% | 33.21% |
| Average Basic Shares Outstanding | 1,338.35% | 2,211.21% | 1,375.93% | 798.70% | 192.79% |
| Average Diluted Shares Outstanding | 1,338.35% | 2,211.21% | 1,375.93% | 798.70% | 192.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |